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O-linked-N-acetylglucosamine (O-GlcNAc) post-translationally modifies and regulates thousands of proteins involved in various
cellular mechanisms. Recently, O-GlcNAc has been linked to human embryonic stem cells (hESC) differentiation, however the
identity and function of O-GlcNAc proteins regulating hESC remain unknown. Here, we firstly identified O-GlcNAc modified
human stem cell regulators such as hnRNP K, HP1γ, and especially RING1B/RNF2. Thereafter, we focused our work on RING1B
which is the catalytic subunit of the polycomb repressive complex 1 (PRC1) a major epigenetic repressor essential for
pluripotency maintenance and differentiation. By point-mutation, we show that T250/S251 and S278 RING1B residues are bearing
O-GlcNAc, and that T250/S251 O-GlcNAcylation decreases during differentiation. O-GlcNAc seems to regulate RING1B-DNA
binding as suggested by our ChIP-sequencing results. Non-O-GlcNAcylated RING1B is found to be enriched near cell cycle genes
whereas O-GlcNAcylated RING1B seems preferentially enriched near neuronal genes. Our data suggest that during hESC
differentiation, the decrease of RING1B O-GlcNAcylation might enable PRC1 to switch its target to induce neuron⁎ Correspondence to: J.J.P. Maury, Institute of Molecular and Cell Biology, 61 Biopolis Drive, #08-01 Proteos, 138673 Singapore. Tel.: +65
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183RING1B O-GlcNAcylation regulates gene targeting of PRC1 in human embryonic stem cellsdifferentiation. Overall, we demonstrate that O-GlcNAc modifies and regulates an essential epigenetic tool, RING1B, which
may contribute to hESC pluripotency maintenance and differentiation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
O-linked N-acetylglucosamine (O-GlcNAc) post-translationally
modifies specific serine and threonine residues from nucleo-
cytoplasmic proteins (Torres and Hart, 1984). O-GlcNAc is
dynamically added and removed by the O-GlcNAc transferase
and hydrolase respectively to regulate protein–protein inter-
action, protein–DNA interaction, and protein stability (Ozcan
et al., 2010). Even though thousands of nucleocytoplasmic
proteins have already been reported (Hart and Akimoto, 2009),
only few studies have recently started to establish a link
betweenO-GlcNAcylation and stem cell pluripotency. O-GlcNAc
transferase was shown to be essential for mouse embryonic
stem cell (mESC) viability (Shafi et al., 2000) and for zebrafish
proper morphogenesis (Webster et al., 2009). In mESC, cell
pluripotency maintenance and somatic cell reprogramming
is regulated by Oct4 O-GlcNAcylation (a pluripotency
transcription factor) (Jang et al., 2012). In addition, mESCFigure 1 hnRNP K, HP1γ, and RING1B are O-GlcNAcylated in hESC.
(IP) O-GlcNAcylated proteins; hnRNP K; HP1γ, and RING1B proteins f
24 h. Of note, in (D) input and IP solutions were run under non-redu
and are difficult to distinguish under reducing conditions. Thus, HP1
condition) to 40 kDa (non-reducing condition). CTD110.6 antibody
O-GlcNAc.cardiac-differentiation was also shown to be controlled by
global levels of O-GlcNAc (Kim et al., 2009). Moreover, we
demonstrated that O-GlcNAc excess increased adipose commit-
ment and decreased ectoderm commitment of differentiating
hESC suggesting that O-GlcNAcylated proteins are regulating
specific hESC differentiation pathways (Maury et al., 2013).
Polycomb repressive complex 1 (PRC1) is an epigenetic
repressor essential for regulating pluripotency maintenance
and differentiation (Rajasekhar and Begemann, 2007). PRC1
catalytic activity subunit, RING1B/RNF2 protein, mono-
ubiquitinylates histone 2A (H2AK119ub) which in turn repress
the expression of genes targeted by PRC1 (Vidal, 2009).
Interestingly, Gambetta et al., 2009 showed in Drosophila
embryos that PRC1 Ring (human RINGs ortholog) was enriched
through its O-GlcNAc modification (supporting material, Fig. S5
Gambetta et al., 2009); suggesting that human RING1B protein
might be O-GlcNAcylated. Interestingly, Speakman C., et al.
also reported recently that some polycomb-target genes in(A–D) Western and Eastern blot analyses of immunoprecipitated
rom hESC treated without (−) or with (+) 100 μM of PUGNAc for
cing conditions because HP1γ and antibody light chain co-elute
γ apparent molecular weight is changed from 25 kDa (reducing
was used for the immunoprecipitation and Eastern blots of
184 J.J.P. Maury et al.mESC had an altered expression following O-GlcNAc excess
(Speakman et al., 2014), suggesting that O-GlcNAc might
directly or indirectly regulate the function of polycomb
proteins.
Here, we started by investigating RING1B O-GlcNAcylation in
hESC. Through various strategies (immunoprecipitation, point-
mutations and mass spectrometry), we demonstrated that
RING1B is O-GlcNAcylated on specific residues T250/S251 and
S278 and that RING1B O-GlcNAcylation decrease during
hESC differentiation. Finally, chromatin immunoprecipita-
tion experiment suggests that O-GlcNAcylation of RING1B
might regulate PRC1 DNA-binding.
Materials and methods
Information related to Material and methods can be found in
the Supplemental information section.Figure 2 RING1B is O-GlcNAcylated at S250/T251 and S278 and R
(A) Overview of RING1B treatment before mass spectrometry analysi
subject to phosphatase treatment to remove phosphate groups. Th
substitute O-GlcNAc group by DTT. Finally, the DTT-modified peptid
(B–C) MS2 analysis of RING1B DTT-modified peptides [(TS)-OGlcNAc]G
and Eastern blots analyses of hESC transfected with empty plasm
mutated versions of HA-RING1B where some residues are substitut
S251A), residue S278 (noted S287A) and the double mutant T250 an
expressed HA-RING1B proteins whereas arrows with tail point out thResults
RING1B is O-GlcNAcylated in hESC
We started by investigating the O-GlcNAcylation of RING1B
by immunoprecipitation in hESC. As a positive control, we
also tested two other stem cell regulators previously
reported as being O-GlcNAcylated: hnRNP K and HP1γ
(Drougat et al., 2012; Gambetta et al., 2009). hnRNP K is a
RNA-binding protein regulating neuronal (Cao et al., 2012)
and erythroid differentiations (Naarmann-de Vries et al., 2013).
HP1γ is a heterochromatin-associated protein involved in gene
repression and differentiation (Morikawa et al., 2013).
In our experiments, hnRNP K, HP1γ, and RING1B were all
detected after IP of O-GlcNAcylated proteins (Fig. 1A). In
addition, a higher amount of these proteins was immuno-
precipitated from cells treated with PUGNAc (O-GlcNAcING1B O-GlcNAcylation decreases during hESC differentiation.
s. Briefly, immunoprecipitated RING1B protein was digested and
en the peptides were subjected to BEMAD reaction in order to
es were enriched on thiopropyl sepharose and analyzed by MS.
NATVDHLSK and GE[S-DTT]NQMNLDTASEK by MS. (D–E) Western
id used as a negative control, HA-RING1B (noted RING1B) and
ed by alanine: residue T250 (noted T250A), residue S251 (noted
d S251 (noted TASA). Arrowheads point out the recombinantly
e native RING1B protein.
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Figure 3 RING1B HexNAcylation decreases during hESC differentiation. (A) Representative LC-MRM-MS trace of RING1B
HexNAcylated peptide (TSGNATVDHLSK + HexNAc). (B) Comparison of the LC-MRM-MS traces of RING1B HexNAcylated peptide
(TSGNATVDHLSK + HexNAc) during hESC differentiation at d4, d7, d14, and d21 post-differentiation. (C) Comparison during hESC
differentiation of the area values from the integration of (TSGNATVDHLSK + HexNAc) traces normalized by the area value of the
non-modified RING1B peptide (Fig. S3D) and GAPDH peptide (Fig. S3E).
185RING1B O-GlcNAcylation regulates gene targeting of PRC1 in human embryonic stem cellshydrolase inhibitor). This is consistent with the conclusion
that these proteins are O-GlcNAcylated (Fig. 1A). These data
were also confirmed by reverse IP of hnRNP K, HP1γ, and
RING1B (Figs. 1B–D).Localizing RING1B O-GlcNAcylation sites
To pinpoint RING1B O-GlcNAcylation sites, we used the
BEMAD reaction to substitute O-GlcNAc (not stable through
MS) by DTT (stable through MS) followed by a mass spectro-
metry (MS) analysis (Fig. 2A) (Wells et al., 2002). Following
this strategy, two RING1B DTT-modified peptides were
detected: [(T250S251)-DTT]GNATVDHLSK (Fig. 2B); and GE[S278-
DTT]NQMNLDTASEK (Fig. 2C). Even though [(T250S251)-
DTT]GNATVDHLSK peptide was identified with a spectrum
containing most of the fragment ions, this spectrum doesn't
allow to precisely pinpoint the DTT modification between
either T250 or S251. To further validate these results, we
recombinantly expressed mutated versions of HA-tagged
RING1B in hESC. Following IP of the recombinant HA-RING1B,we
show that the simple mutation of T250 (T250A), S251 (S251A) as
well as the double mutation (TASA) into alanine all reduced
HA-RING1B O-GlcNAcylation (Fig. 2D). These data suggest thatboth T250 and S251 residues are necessary for proper RING1B
O-GlcNAcylation. Similarly, S278 simple mutation (S278A)
reduced HA-RING1B O-GlcNAcylation (Fig. 2E). Then, it can
be concluded that S278 residue is O-GlcNAc modified and that
T250 and S251 are both required for proper O-GlcNAcylation of
RING1B thus assuming that one of the two residues (either T250
or S251) is bearing O-GlcNAc while the other residue is probably
important for the binding of the O-GlcNAc transferase to this
RING1B region.
We later investigated RING1B O-GlcNAcylation changes
during differentiation which may be important for hESC
differentiation. hESC were spontaneously differentiated (as
previously reported (Maury et al., 2013)) and studied using
a multiple reaction monitoring MS (MRM-MS) method we
developed to quantify O-GlcNAc peptides (Maury et al.,
2014). It is worth noting that such a method is, like all the MS
methods, unable to differentiate the O-GlcNAc from its
isomer O-GalNAc. Therefore, here, we will use the term of
N-acetylated hexosamine (HexNAc) to describe both isomers
even though O-GalNAc is mostly found on membrane and
extracellular proteins (Brockhausen et al., 2009) and has a
low chance of being found on nucleocytoplasmic proteins,
such as RING1B. The MRM-MS strategy allowed us to detect
the native [(T250S251)-HexNAc]GNATVDHLSK RING1B peptide
186 J.J.P. Maury et al.in hESC (Fig. 3A) and quantify the increase of this HexNAcylated
peptide following cell treatment with PUGNAc (Figs. S1A–
C). Unfortunately, MRM-MS method was unable to detectthe other GE[S278-HexNAc]NQMNLDTASEK peptide, proba-
bly due to the low stoichiometry of this specific HexNAc
peptide. Interestingly, the ratio of the total amount of
187RING1B O-GlcNAcylation regulates gene targeting of PRC1 in human embryonic stem cellsRING1B that is HexNAcylated decreased during hESC dif-
ferentiation, as shown by monitoring the amount of native
(TSGNATVDHLSK + HexNAc) peptide during this process
(Figs. 3B, C and S1D, E).
These data suggest that O-GlcNAcylation on TSGNATVDHLSK
might be functionally important during hESC differentiation.
Considering that during differentiation RING1B targets and
represses specific developmental-genes, we hypothesized
that O-GlcNAcylation of RING1B might regulate RING1B
DNA-binding.O-GlcNAc regulate RING1B DNA-binding
To determine if O-GlcNAcylation regulates RING1B DNA-
binding, we carried out a chromatin immunoprecipitation
sequencing (ChIP-Seq) experiment (Fig. 4A). To collect
sufficient chromatin material for running this experiment
from hESC, we expressed recombinantly HA-RING1B and
performed a first ChIP to enrich RING1B-bound chromatin
followed by a re-ChIP to enrich for O-GlcNAcylated RING1B-
bound chromatin. Of note, this strategy might also enrich for
other GlcNAcylated proteins being associated with RING1B
(such as OCT4, Pol II, Histones and others). Using this
strategy, we confirmed the quality of our sequenced DNA
(Fig. S2A, B), and identified a total of 6507 genes bound by
RING1B among which 1596 genes are bound by O-GlcNAcylated
RING1B (Fig. 4B).
Moreover, we found that RING1B bound slightly down-
stream relative to the transcription start site of genes
(Fig. 4C) which is highly similar to a previous report done on
mESC Ring1b (Morey et al., 2013). By gene ontology, we
found that non-O-GlcNAcylated RING1B-bound genes were
mainly related to metabolism and cell cycle processes;
whereas O-GlcNAcylated RING1B-bound genes were mainly
related to neural differentiation processes (Fig. 4D). Indeed,
many neural developmental genes (PAX6, LHX2, RAC2 and
others) were bound by O-GlcNAcylated RING1B (Fig. S2C).
Interestingly, by comparing our data with reports of ChIP-Seq
done specifically on OCT4, SOX2, and NANOG in hESC
(Watanabe et al., 2014, p. 63; Gertz et al., 2013); we found
that O-GlcNAcylated RING1B preferentially bound to genes
co-occupied by the pluripotency core network (Figs. 4E, S2D).
These data suggest that O-GlcNAcylated RING1B preferentially
binds near stem cell-related genes and more specifically neural
developmental-genes.
By taking into account the decrease of RING1B O-
GlcNAcylation during differentiation (Fig. 3C); we can finally
hypothesize a functional model for the O-GlcNAcylation of
RING1B (outlined in Fig. 4F). In this model, hESC maintenance
and growth might be promoted by high level of O-GlcNAcylated
RING1B which indirectly increases the expression of genes
related to cell growth and metabolism. A contrario,Figure 4 RING1B O-GlcNAcylation regulates RING1B gene targetin
O-GlcNAcylated RING1B. (B) Veen diagrams of the overlap betwee
RING1B. (C) Normalized signal of the binding profiles of RING1B (bl
transcription start site (TSS) of genes. (D) GO comparison between
non-O-GlcNAcylated RING1B. (E) Co-occupancy between O-GlcNAcy
and SOX2 on genes. Data related to the identity of genes bound by O
Gertz et al., 2013). (F) Hypothetical model for the function of O-Glcneuronal differentiation might be promoted by low level
of O-GlcNAcylated RING1B which indirectly increases the
expression of genes related to neuronal differentiation.Discussion
We previously reported that O-GlcNAcylation is important in
hESC commitment towards adipose and ectoderm lineages
(Maury et al., 2013). However, O-GlcNAc proteins regulating
hESC commitment have yet to be characterized. Here, we
aimed at extending our understanding of O-GlcNAc regula-
tion occurring during human stem cell differentiation.
Therefore, we revealed for the first time that RING1B,
the catalytic core of PRC1, is O-GlcNAcylated in hESC. We
revealed that RING1B has at least 2 O-GlcNAcylation sites
which are occupied and linked to specific residues: T250/
S251 and S278 respectively. Interestingly, the relative
percentage of RING1B O-GlcNAcylation on T250/S251 residue
decreases during differentiation. We then studied the
function of RING1B O-GlcNAcylation using an anti-RING1B ChIP
strategy followed by a WGA re-ChIP experiment. Functionally,
O-GlcNAcylation on RING1B seemed to modulate RING1B
DNA-binding. Non-O-GlcNAc RING1B preferentially bound near
genes related tometabolic and cell cycle processes. In contrast,
O-GlcNAcylated RING1B preferentially bound near genes relat-
ed to neural differentiation. Several groups have previously
shown that PRC1 can switch gene targets leading to specific cell
phenotypes (Rajasekhar and Begemann, 2007; Chen et al.,
2011). Our data suggest that O-GlcNAc functions might regulate
RING1B DNA-binding and potentially RING1B gene targeting.
Therefore, change in RING1B O-GlcNAcylation might be one
of the mechanisms enabling PRC1 to switch its gene
targets. As RING1B O-GlcNAcylation decreases during hESC
differentiation, O-GlcNAcylated RING1B-bound genes (re-
lated to neuron differentiation) might be de-repressed in
favor of non-O-GlcNAcylated RING1B-bound genes (related
to metabolism and cell cycle) (Fig. 3F). This hypothetical
mechanism might be necessary during differentiation to 1)
slow down cell growth, and 2) direct stem cell differenti-
ation towards neuronal lineage. This is in contrast with
maintained hESC where the higher level of O-GlcNAcylated
RING1B might prevent neuronal differentiation whereas lower
level of non-O-GlcNAcylated RING1B might promote the ex-
pression of genes related to metabolism and cell cycle. Such
mechanism may be necessary in maintained hESC to promote
cell growth.
We previously showed that O-GlcNAc excess in differen-
tiating hESC leads to an 80% mRNA and protein expression
decrease for PAX6 (neuronal lineage marker) (Maury et al.,
2013). Interestingly, we demonstrated here that PAX6 is
bound by O-GlcNAcylated RING1B. This suggests that O-
GlcNAcylation increase on RING1B might be one of theg. (A) Overview of the re-ChIP process to enrich DNA bound by
n genes bound by RING1B and genes bound by O-GlcNAcylated
ack line) and O-GlcNAcylated RING1B (red line) relative to the
genes bound by O-GlcNAcylated RING1B and genes bound by
lated RING1B, non-O-GlcNAcylated RING1B and OCT4, NANOG,
CT4, NANOG or SOX2 were taken from (Watanabe et al., 2014;
NAc RING1B on the regulation of hESC differentiation.
188 J.J.P. Maury et al.reasons for the previously observed effect of O-GlcNAc excess
on hESC differentiation.
Mechanistically, O-GlcNAc is probably not directly regu-
lating RING1B binding to chromatin as RING1B is not known
to bind to either histone or DNA (Vidal, 2009). Instead,
O-GlcNAc might be regulating RING1B binding to PRC1
recruitment subunit (CBX2, 4, 6, 7, 8 and RYBP) which are
known to bind to specific gene subsets (Vincenz and Kerppola,
2008; Morey et al., 2013). As RING1B can only bind to one CBXs/
RYBP protein (Bezsonova et al., 2009; Wang et al., 2010); each
CBXs/RYBP protein will form different PRC1 variants which are
thought to target and repress specific gene subsets (Vincenz and
Kerppola, 2008; Morey et al., 2013). In addition, RING1B
O-GlcNAcylation sites appear in a region (from I248 to P324)
previously reported as mediating the exclusive binding of
RING1B to CBX7 and RYBP (Bezsonova et al., 2009; Wang
et al., 2010). Altogether, these data suggest that RING1B
O-GlcNAcylation might regulate RING1B affinity for PRC1
recruitment subunit (CBXs/RYBP) ultimately modulating PRC1
DNA-binding.
In summary, we report for the first time that a major
epigenetic tool, RING1B, is modified by O-GlcNAc. Our data
suggest that RING1B O-GlcNAcylation may regulate PRC1
DNA-binding and might be an essential regulator of stem cell
growth and differentiation.
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